This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Dr. Reddy's To Release Q1 FY13 Results On July 19, 2012

Dr. Reddy's Laboratories (NYSE: RDY) will announce results for the First Quarter ended June 30, 2012 on Thursday, July 19, 2012 after the Board Meeting. The results will be available on the Company’s website www.drreddys.com.

Summary of Events

Event       Date and Time (IST)       Medium
Release of financial results       July 19, after the Board Meeting      

Email, Media, Company website, Business Wire

Earnings Call       July 19, 6.30 PM IST / 9:00 AM EST       Hosted by the Company

(Details below)

Webcast of Earnings Call       July 19, 6.30 PM IST / 9.00 AM EST through July 24, 2012      

URL available on Company’s website,

www.drreddys.com

Transcripts of the Earnings call       Will be available on the Company’s website      

URL available on Company’s website, www.drreddys.com

           

Earnings Call

Following the release, the management of the Company will host an earnings call to discuss the Company’s financial performance.

Conference Dial-In Numbers
Primary Number:       +91 22 3065 0136
Secondary Number:       +91 22 6629 0356
The numbers listed above are universally accessible from all networks and all countries.
Local Access Number:      

6000 1221 Available in - Delhi, Bangalore, Chennai, Hyderabad, Kolkata Accessible from all major carriers except BSNL/MTNL.

3940 3977

Available in - Gurgaon (NCR), Bangalore, Kolkata, Cochin, Pune,Lucknow, Ahmedabad, Chandigarh

Accessible from all carriers.

International Toll Free Number:       USA: 1 866 746 2133

UK: 0 808 101 1573

Singapore: 800 101 2045

Hong Kong: 800 964 448

 

No password/pin number is necessary to dial in to any of the other calls. As participation in the call is limited, early registration is encouraged. The operator will provide instructions on asking questions before and during the call.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 18,232.02 -53.72 -0.29%
S&P 500 2,126.06 -4.76 -0.22%
NASDAQ 5,089.3620 -1.4320 -0.03%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs